Looks like it's just an extension of this patent (as I suspected)
System and Method For Using, Processing, and Displaying Biometric Data
Patent was amended to this on 05-17-2020, well after covid.
As someone who has been granted more than 10 US patents, IMO I really don't see anything fishy here. Just someone trying to capitalize on covid and take advantage of the fact that the USPTO is slow.
So I looked up each of these patents on the website. All of the ones prior to the latest one are about using a device to record and display biometric data.
This patent is the only one that mentions Covid-19. They likely want to integrate it into their biometric testing platform which is not shady at all.
I created account when I saw this because I don't want you all to get excited about this. I'm no patent attorney but I am a physician. For what it is worth.
I read the summary of the 2015 provisional patent. It mentions nothing about Covid-19. This September 2020 patent that mentions Covid-19 is likely a supplement to their original generic proposal of a vital signs/biometric display. Likely adding Covid-19 testing as an option for remote testing and data display.
It's for the use of common medical equipment combined with sensors in a phone to "verify" the results my measuring the movement of the patient. Pulse Oximeter measures heart rate and blood oxygen saturation. The mention of COVID-19 was added when the patent application was updated in September, 2020.
The key word here is "RELATED" Patent documents. These references documents from 2015 are RELATED to this one but ARE NOT this one. I don't know what they're patenting because I don't know how to search for these, but they're not the same patent application.
(Aug. 27, 2019) On June 29, 2019, the National People’s Congress Standing Committee of the People’s Republic of China (PRC or China) adopted the PRC Law on Vaccine Administration (Vaccine Law). The official Xinhua news agency states that the Law provides for the “strictest” vaccine management with tough penalties in order to ensure the country’s vaccine safety.
Before the passage of this 100-article Law, provisions governing vaccines were contained in the PRC Drug Administration Law, PRC Law on the Prevention and Treatment of Infectious Diseases, and a few relevant administrative regulations and rules.
The new Law provides for regulatory requirements for researching, producing, distributing, and using vaccines. Such requirements, according to one legal commentator, are much more stringent than those for other drugs (art. 2). It also contains a chapter specifying penalties for violating the Vaccine Law, which are also stricter than those for violating other drug laws (ch. 10). According to the Law, if any violation of this Law constitutes a crime, a “heavier punishment” within the range of punishments provided by the Criminal Law on the relevant crimes is to be imposed (art. 79).
The Law mandates the launching of a national vaccine electronic tracking platform that integrates tracking information throughout the whole process of vaccine production, distribution, and use to ensure all vaccine products can be tracked and verified (art. 10).
According to the Law, China is to implement a state immunization program, and residents living within the territory of China are legally obligated to be vaccinated with immunization program vaccines, which are provided by the government free of charge. Local governments and parents or other guardians of children must ensure that children be vaccinated with the immunization program vaccines (art. 6).
The Law establishes a compensation system for abnormal reactions to vaccination. A recipient of an immunization program vaccine who dies or suffers significant disability or organ and tissue damage is to be paid from the vaccination funds of the provincial level government if the damage falls within the scope of abnormal reactions associated with a vaccine or cannot be prevented (art. 56).
The Law will take effect on December 1, 2019 (art. 100).
Author: Laney Zhang
Topic: Drug safety, Health promotion and preventive care, Public health
Jurisdiction: China
Date: August 27, 2019
Patent lawyer here. This is a continuation-in-part patent application. It claims the priority date of the earlier (2015) filing, but it incorporates new material (COVID) in the more recent filing. This isn’t anything unusual.
This patent was filed in Sept 2020. The red box is highlighting a "Related Application Data" section. Meaning that this is a related patent that was provisionally applied for in 2015. I don't know how or if these provisional applications are searchable anywhere, but it's very possible that this is just a patent for a similar kind of test for something else.
Provisional application for this patent is shown as 2015. That is for this patent. Need to verify real.
No, provisional application for the referenced prior art was filed in 2015. Hence the different patent number.
It's not real, the patent filed in 2015 they are referencing is here https://patents.google.com/patent/US20170229149A1/en
It's just someone that doesn't understand what they are looking at.
The title of the post is not accurate, it's a lie. Facts and truth matter.
Gonna do some digging on this, but if I had to guess, they amended a similar patent post-covid.
Edit: found the patent. Seeing if I can find a record of the original.
https://patents.google.com/patent/US20200279585A1/en?oq=US20200279585
Edit 2: https://patents.google.com/patent/US20200126593A1/en?assignee=Richard+A.+ROTHSCHILD
Looks like it's just an extension of this patent (as I suspected)
Patent was amended to this on 05-17-2020, well after covid.
As someone who has been granted more than 10 US patents, IMO I really don't see anything fishy here. Just someone trying to capitalize on covid and take advantage of the fact that the USPTO is slow.
Cane to say this. If that's real this was all planned BEFORE Trump got elected
So I looked up each of these patents on the website. All of the ones prior to the latest one are about using a device to record and display biometric data.
This patent is the only one that mentions Covid-19. They likely want to integrate it into their biometric testing platform which is not shady at all.
I created account when I saw this because I don't want you all to get excited about this. I'm no patent attorney but I am a physician. For what it is worth.
The only correct answer in here.
Grab a coat and stay a while
I read the summary of the 2015 provisional patent. It mentions nothing about Covid-19. This September 2020 patent that mentions Covid-19 is likely a supplement to their original generic proposal of a vital signs/biometric display. Likely adding Covid-19 testing as an option for remote testing and data display.
Thats not how patent filing works idiot.
Notice the completely different application number next to 2015?
It's for the use of common medical equipment combined with sensors in a phone to "verify" the results my measuring the movement of the patient. Pulse Oximeter measures heart rate and blood oxygen saturation. The mention of COVID-19 was added when the patent application was updated in September, 2020.
The key word here is "RELATED" Patent documents. These references documents from 2015 are RELATED to this one but ARE NOT this one. I don't know what they're patenting because I don't know how to search for these, but they're not the same patent application.
https://archive.vn/xtIwX https://www.loc.gov/law/foreign-news/article/china-vaccine-law-passed/
China: Vaccine Law Passed
(Aug. 27, 2019) On June 29, 2019, the National People’s Congress Standing Committee of the People’s Republic of China (PRC or China) adopted the PRC Law on Vaccine Administration (Vaccine Law). The official Xinhua news agency states that the Law provides for the “strictest” vaccine management with tough penalties in order to ensure the country’s vaccine safety. Before the passage of this 100-article Law, provisions governing vaccines were contained in the PRC Drug Administration Law, PRC Law on the Prevention and Treatment of Infectious Diseases, and a few relevant administrative regulations and rules.
The new Law provides for regulatory requirements for researching, producing, distributing, and using vaccines. Such requirements, according to one legal commentator, are much more stringent than those for other drugs (art. 2). It also contains a chapter specifying penalties for violating the Vaccine Law, which are also stricter than those for violating other drug laws (ch. 10). According to the Law, if any violation of this Law constitutes a crime, a “heavier punishment” within the range of punishments provided by the Criminal Law on the relevant crimes is to be imposed (art. 79).
The Law mandates the launching of a national vaccine electronic tracking platform that integrates tracking information throughout the whole process of vaccine production, distribution, and use to ensure all vaccine products can be tracked and verified (art. 10).
According to the Law, China is to implement a state immunization program, and residents living within the territory of China are legally obligated to be vaccinated with immunization program vaccines, which are provided by the government free of charge. Local governments and parents or other guardians of children must ensure that children be vaccinated with the immunization program vaccines (art. 6).
The Law establishes a compensation system for abnormal reactions to vaccination. A recipient of an immunization program vaccine who dies or suffers significant disability or organ and tissue damage is to be paid from the vaccination funds of the provincial level government if the damage falls within the scope of abnormal reactions associated with a vaccine or cannot be prevented (art. 56). The Law will take effect on December 1, 2019 (art. 100).
Author: Laney Zhang Topic: Drug safety, Health promotion and preventive care, Public health Jurisdiction: China Date: August 27, 2019
Deport this shit.
Notice the heading of paragraph 60?
Related U.S. Application Data
Application 62/240,783 was filed on a RELATED item in 2015. This is Application 16/876,114 - FILED IN 2019.
You just are demonstrating your inability to read.
Yo.
Walk a dumb pede on how to do the search myself. If you would.
Patent lawyer here. This is a continuation-in-part patent application. It claims the priority date of the earlier (2015) filing, but it incorporates new material (COVID) in the more recent filing. This isn’t anything unusual.
Did anybody watch “Fall of the Cabal” just saying???
https://www.reuters.com/article/uk-factcheck-patent/fact-check-rothschild-did-not-patent-a-test-for-covid-19-in-2015-and-2017-idUSKBN27C34O
Honestly the debunk sounds legit
That's strange considering 19 represents the year of discovery.
This patent was filed in Sept 2020. The red box is highlighting a "Related Application Data" section. Meaning that this is a related patent that was provisionally applied for in 2015. I don't know how or if these provisional applications are searchable anywhere, but it's very possible that this is just a patent for a similar kind of test for something else.
Is there some way to find this on the wayback archive?
I see someone hasn't been following Alex Jones...
This is a link https://patents.google.com/patent/US20200279585A1/en?oq=16%2f876114 Rothschild have their fingers in every pie. They own 2/3 of the earth
RELATED prior art.
Chances are this is in relation to this study of corona viruses in the bat population that was done after the first sars virus.
https://cmr.asm.org/content/20/4/660
look at all his post its all conspiracy bull shit /deport
Did some digging and reposted TDW content. Well done.
it's a reference in the patent - not THEIR provisional, they only last a year.
Yea I've seen this. This https://www.google.com/amp/s/silview.media/2020/10/04/atomic-bombshell-rothschilds-patented-covid-19-biometric-tests-in-2015-and-2017/amp/
Check this pede's link out, same deal except in Dutch:
https://thedonald.win/p/11QRotvjt3/redpill-alert--german-filing-for/